Advertising Disclaimer
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitanchez-Mokhtari, D.
Right arrow Articles by Voyer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitanchez-Mokhtari, D.
Right arrow Articles by Voyer, M.
Related Collections
Right arrow Endocrinology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 113 No. 3 March 2004, pp. 537-541

Both Relative Insulin Resistance and Defective Islet ß-Cell Processing of Proinsulin Are Responsible for Transient Hyperglycemia in Extremely Preterm Infants

Delphine Mitanchez-Mokhtari, MD, PhD*, Najiba Lahlou, MD{ddagger}, François Kieffer, MD§, Jean-François Magny, MD§, Marc Roger, MD{ddagger}, Marcel Voyer, MD§

* Service de Réanimation Pédiatrique et Néonatale, Hôpital Necker-Enfants Malades, Paris, France
{ddagger} Laboratoire d’Hormonologie, Hôpital Saint Vincent de Paul, Paris, France
§ Service de Néonatologie, Institut de Puériculture, Paris, France

Objective. Many extremely preterm infants develop hyperglycemia in the first week of life during continuous glucose infusion. The objective of this study was to determine whether defective insulin secretion or resistance to insulin was the primary factor involved in transient hyperglycemia of extremely preterm infants.

Methods. A prospective comparative study was conducted in appropriate-for-gestational-age preterm infants <30 weeks of gestational age with the aim specifically to evaluate the serum levels of proinsulin, insulin, and C-peptide secreted during transient hyperglycemia by specific immunoassays. Three groups of infants were investigated hyperglycemic (n = 15) and normoglycemic preterm neonates (n = 12) and normal, term neonates (n = 21). In addition, the changes in ß-cell peptide levels were analyzed during and after intravenous insulin infusion in the hyperglycemic group. Data were analyzed using analysis of variance and analysis of variance for repeated measures.

Results. At inclusion, insulin and C-peptide levels did not differ in hyperglycemic subjects and in preterm controls. Proinsulin concentration was significantly higher in the hyperglycemic group (36.5 ± 3.9 vs 23.2 ± 0.9 pmol/L). Compared with term neonates, proinsulin and C-peptide levels were higher in normoglycemic preterm infants (23.2 ± 0.9 vs 18.9 ± 2.71 pmol/L and 1.67 ± 0.3 vs 0.62 ± 0.12 nmol/L, respectively). During and after insulin infusion in hyperglycemic neonates, plasma glucose concentration fell and proinsulin and C-peptide levels were lowered (18.4 ± 7.6 and 20.7 ± 4.5 pmol/L, respectively).

Conclusion. These data suggest that 1) preterm neonates are sensitive to changes in plasma glucose concentration, but proinsulin processing to insulin is partially defective in hyperglycemic preterm neonates; 2) hyperglycemic neonates are relatively resistant to insulin because higher insulin levels are needed to achieve euglycemia in this group compared with normoglycemic neonates. These results also show that insulin infusion is beneficial in extremely preterm infants with transient hyperglycemia.

Key Words: extremely preterm infants • hyperglycemia • insulin-resistance • proinsulin processing

Abbreviations: EPI, extremely preterm infant • SEM, standard error of the mean

Received for publication Jan 24, 2003; Accepted Jun 3, 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
G. Van den Berghe, D. Vlasselaers, I. Vanhorebeek, W. M. Fendler, W. M. Mlynarski, K. Beardsall, F. de Zegher, D. B. Dunger, the NIRTURE Investigators, S. Kashyap, et al.
Insulin Therapy in Very-Low-Birth-Weight Infants
N. Engl. J. Med., January 29, 2009; 360(5): 535 - 537.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
V R Kairamkonda, A Deorukhkar, C Bruce, R Coombs, R Fraser, and A-P T Mayer
Amylin peptide is increased in preterm neonates with feed intolerance
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F265 - F270.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Johansson, A. Iliadou, N. Bergvall, T. Tuvemo, M. Norman, and S. Cnattingius
Risk of High Blood Pressure Among Young Men Increases With the Degree of Immaturity at Birth
Circulation, November 29, 2005; 112(22): 3430 - 3436.
[Abstract] [Full Text] [PDF]